Q0138 – Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)

Long description

Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)

Short description

Ferumoxytol, non-esrd

Pricing indicator

51 Drugs

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

O1E Other drugs

ASC

Approved for ambulatory surgical centers

Added

January 1, 2010

Last change

January 1, 2010 – No change

Nearby Q codes

• Q0085 – Chemotherapy administration by both infusion technique and other technique(s) (e.g., subcutaneous, intramuscular, push), per visit
• Q0091 – Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory
• Q0092 – Set-up portable x-ray equipment
• Q0111 – Wet mounts, including preparations of vaginal, cervical or skin specimens
• Q0112 – All potassium hydroxide (koh) preparations
• Q0113 – Pinworm examinations
• Q0114 – Fern test
• Q0115 – Post-coital direct, qualitative examinations of vaginal or cervical mucous
• Q0139 – Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)
• Q0144 – Azithromycin dihydrate, oral, capsules/powder, 1 gram
• Q0155 – Dronabinol (syndros), 0.1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
• Q0161 – Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
• Q0162 – Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
• Q0163 – Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen
• Q0164 – Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
• Q0166 – Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen